These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: A TSP-1 functional fragment inhibits activation of latent transforming growth factor-beta1 derived from rat alveolar macrophage after bleomycin treatment.
    Author: Chen Y, Wang X, Weng D, Tao S, Lv L, Chen J.
    Journal: Exp Toxicol Pathol; 2009 Jan; 61(1):67-73. PubMed ID: 18722097.
    Abstract:
    The antineoplastic antibiotic, bleomycin, is known to induce a well-recognized model of lung fibrosis. Active transforming growth factor-beta1 (TGF-beta1) plays a key role in lung fibrosis induced by bleomycin, TSP-1 (thrombospondin-1) being critical to the activation of L (latent)-TGF-beta1 by virtue of an association of the TSP-1/L-TGF-beta1 complex with CD36, involving the sequence CSVTCG of the TSP-1 functional fragment. To observe the inhibitory effects of TSP-1 functional fragments, critical for CD36 binding, on the activation of L-TGF-beta1, we isolated alveolar macrophages from Wistar rat lungs 7 days after bleomycin administration (5mg/kg body weight) and cultured the cells with or without TSP-1 functional or control fragments. We observed a cell surface association of TGF-beta1 with CD36 by immunofluorescence and quantified the active and total TGF-beta1 by ELISA. The co-localization of CD36 with TGF-beta1, shown by a yellow fluorescence deriving from a mixture of the green and red of the two components, for the TSP-1 functional fragment groups was clearly less than that of the TSP-1 control fragment groups. The quantities and the percentages of active TGF-beta1 in the TSP-1 functional fragment groups were lower than those in the TSP-1 control fragment groups (P<0.05 or P<0.01). These findings suggest that TSP-1 functional fragments could inhibit the activation of L-TGF-beta1 secreted by activated alveolar macrophages through blocking the binding of TSP-1 to CD36.
    [Abstract] [Full Text] [Related] [New Search]